financetom
Market
financetom
/
Market
/
Should you buy, sell or hold Grasim shares after Q1 earnings? Here's what brokerages say
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Should you buy, sell or hold Grasim shares after Q1 earnings? Here's what brokerages say
Aug 16, 2021 5:22 AM

Grasim Industries shares slipped into negative territory in afternoon deals on Monday erasing the gains registered the previous day. On Friday, the flagship company of conglomerate Aditya Birla Group had reported a standalone net profit of Rs 481.6 crore for the June quarter, beating Street estimates.

Share Market Live

NSE

Grasim's revenue came in at Rs 3,762.7 crore in the June quarter, as against Rs 1,335.7 crore a year ago. The company's EBITDA came in at Rs 740.3 crore in the quarter, as against an EBITDA loss of Rs 225.6 crore in the year-ago period, and its EBITDA margin was at 19.7 percent.

Analysts in a CNBC-TV18 poll had estimated the company's profit at Rs 311 crore over revenue of Rs 3,710 crore. They had predicted its EBITDA at Rs 628 crore and the EBITDA margin at 16.93 percent.

Read more on Grasim Industries' Q1 results here

Here's what brokerages said on the company's Q1 performance:

ICICI Securities

The brokerage said Grasim Industries' standalone EBITDA in Q1 was above its estimates led by improved profitability across both the viscose staple fibre and chemicals segments. It expects the company's expansion to drive volume growth going forward. ICICI Securities has maintained an 'add' rating on the stock with a target price of Rs 1,498.

Grasim achieved the EU’s best available technology compliance at the VSF Vilayat site, which is expected to drastically reduce its sulphur-to-air emission by 85 percent. The Nagda plant is likely to be the first to achieve zero liquid discharge in the viscose industry which is expected to be completed by Q2.

Motilal Oswal

The brokerage has maintained a 'neutral' rating on the stock with a target price of Rs 1,590. The company's Q1 performance surprised positively on the EBITDA margin front driven by sustained cost reduction and better realisation in the chemicals business, according to Motilal Oswal.

The brokerage raised its FY22E and FY23E standalone EBITDA estimate by 18 percent and six percent respectively to factor in an improved demand outlook and better margin for both the viscose staple fibre and chemicals segments. The holding company discount of 46 percent is in line with the 10-year average of 48 percent, said Motilal Oswal.

JPMorgan

Grasim reported relatively strong quarterly earnings with a recovery in the chemicals segment, said the brokerage, which has maintained an 'overweight' rating on the stock with a target price of Rs 1,820. New project commissioning in H2 should drive volume growth for the company over FY22-23, according to JPMorgan.

At 2 pm, the Grasim stock traded 0.39 percent lower at Rs 1,491.75 apiece on BSE, underperforming the headline Sensex index, which was up 0.25 percent.

Catch latest market updates here

Catch more on quarterly results here

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Sector Update: Energy
Sector Update: Energy
Aug 1, 2024
01:31 PM EDT, 08/01/2024 (MT Newswires) -- Energy stocks fell Thursday afternoon with the NYSE Energy Sector Index declining 2.3% and the Energy Select Sector SPDR Fund (XLE) dropping 2.6%. The Philadelphia Oil Service Sector index slumped 4.6%, and the Dow Jones US Utilities index rose 1.7%. West Texas Intermediate crude oil fell 1.2% to $76.97 a barrel, while global...
Sector Update: Health Care
Sector Update: Health Care
Aug 1, 2024
01:38 PM EDT, 08/01/2024 (MT Newswires) -- Health care stocks advanced Thursday afternoon with the NYSE Health Care Index and the Health Care Select Sector SPDR Fund (XLV) both up 0.8%. The iShares Biotechnology ETF (IBB) fell 0.8%. In corporate news, Moderna ( MRNA ) shares tumbled 21%. The company reported better-than-expected Q2 results but lowered the full-year product sales...
Pineapple Financial And 2 Other Penny Stocks Insiders Are Buying
Pineapple Financial And 2 Other Penny Stocks Insiders Are Buying
Aug 1, 2024
The Dow Jones index closed higher by around 99 points on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company’s prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision. Below is a look at a few recent notable insider transactions for penny...
Sector Update: Tech
Sector Update: Tech
Aug 1, 2024
01:36 PM EDT, 08/01/2024 (MT Newswires) -- Tech stocks tumbled Thursday afternoon with the Technology Select Sector SPDR Fund (XLK) dropping 3.8% and the SPDR S&P Semiconductor ETF (XSD) slumping 6.2%. The Philadelphia Semiconductor index plunged 6.9%. In corporate news, Qualcomm ( QCOM ) shares fell 9.3%. The company reported better-than-expected fiscal Q3 results amid strong automotive sales growth but...
Copyright 2023-2025 - www.financetom.com All Rights Reserved